The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or...
The National Institutes of Health awarded a $50.7 million firm fixed price modification to MicroGEM US Inc. under the RADX Tech Program. The modification extends an existing contract to maintain MicroGEM's production of 160,000 saliva-based, high-performing RT-PCR point-of-care cartridges and 1,000 portable devices per day for COVID-19 testing. The 25-minute tests and devices are non-invasive and portable. Funding comes from the Department of Health and Human Services National Institutes of...
This definitive contract from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awards Nanomix, Inc. $569,647 to develop rapid antigen and antibody tests for COVID-19. The contract aligns with Special Instructions 019 under the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which seeks host-directed therapeutic candidates to improve long-term outcomes from lung injury. As the prime contractor, Nanomix will perform work in...
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
This $300,000.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Avantgen Inc., a small biotechnology company based in San Diego, California. The contract is for the development of a rapid and point-of-care diagnostic kit for the detection of the hepatitis C virus. This award is part of NIAID's solicitation for...
Siemens Healthcare Diagnostics Inc. was awarded an $11.95 million firm fixed price purchase order by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop the SARS-CoV-2 Antigen (CoV2Ag) test for the Advia Centaur and Atellica IM diagnostic platforms. The contract aims to support the government's response to the Coronavirus Disease 2019 pandemic by facilitating testing capabilities. As the prime contractor, Siemens Healthcare...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Siemens Healthcare Diagnostics Inc. a $13 million firm fixed price purchase order to develop SARS-CoV-2 antigen tests for the Advia Centaur and Atellica IM systems. As the prime contractor, Siemens Healthcare Diagnostics will deliver coronavirus COVID-19 testing capabilities to support the agency's response efforts. The tests will be developed and the contract performed in Norwood,...
This is a $354,267.22 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Grip Molecular Technologies Inc., a small disadvantaged business. The contract involves research and development of ultra-sensitive photonic integrated circuit detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza A antigens using graphene biosensors. The goal is to support the...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded an $18.2 million firm fixed price definitive contract to Quanterix Corporation as part of the Rapid Acceleration of Diagnostics initiative. The RADx program aims to expedite the development, commercialization, and implementation of Covid-19 testing technologies to significantly increase domestic testing capacity. Quanterix will support this objective through the delivery of diagnostic solutions over a two-year...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...